EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Implementation and One-Year Evaluation of Proenkephalin A in Critical Care

Lukas Martin, Caren Martin iD, Arne Peine, Matthias Imöhl iD, Alexander Kersten iD, Rafael Kramann, Turgay Saritas iD, Nikolaus Marx, Michael Dreher iD, Gernot Marx, Tim-Philipp Simon

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26062602 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Lukas Martin und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Medicine, Faculty of Medicine, RWTH Aachen University, 52074 Aachen, Germany. Hauptthemen laut MEDLINE: Enkephalins, Critical Care, Acute Kidney Injury, Protein Precursors. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Proenkephalin A 119–159 (PENK) is a promising functional kidney biomarker, evaluated in various clinical settings. In critical care medicine, early diagnosis of acute kidney injury (AKI) is crucial; however, to date, the diagnosis and the assessment of kidney function is still based on serum creatinine (sCr) and urine output, both associated with several limitations. Between November 2020 and March 2022, we implemented PENK in our daily practice on our intensive care units (ICU). PENK, sCr, AKI stage, and the start and duration of renal replacement therapy (RRT) were documented. Almost 18,000 PENK measurements from 4169 patients were analyzed, and the glomerular filtration rate (GFR) was estimated with the new PENK-GFR formula. PENK outperformed sCR in the kidney function assessment and sCR trajectory over time. Moreover, PENK predicted the use of RRT and thus showed its usefulness in critical care daily practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EnkephalinsCritical CareAcute Kidney InjuryProtein PrecursorsHumansMaleFemaleGlomerular Filtration RateMiddle AgedBiomarkersAgedCreatinineIntensive Care UnitsRenal Replacement Therapy

Stichwörter der Autor:innen

AKIPENKcritical carekidney function biomarkerproenkephalin Aproenkephalin A 119–159

Substanzen

EnkephalinsproenkephalinProtein PrecursorsBiomarkersCreatinine

Autor:innen und Institutionen

  • Department of Intensive Care Medicine, Faculty of Medicine, RWTH Aachen University, 52074 Aachen, Germany.
  • Laboratory Diagnostic Center, University Hospital RWTH Aachen, 52074 Aachen, Germany.
  • Department of Pneumology and Intensive Care Medicine, University Hospital RWTH Aachen, 52074 Aachen, Germany.
  • Department of Cardiology, Angiology and Internal Intensive Care Medicine, University Hospital RWTH Aachen, 52074 Aachen, Germany.
  • Department of Nephrology, Rheumatology, Clinical Immunology and Hypertension, University Hospital RWTH Aachen, 52074 Aachen, Germany.

ORCID-Profile: Caren Martin, Matthias Imöhl, Alexander Kersten, Turgay Saritas, Michael Dreher

Zitieren

APA

Martin, L., Martin, C., Peine, A., Imöhl, M., Kersten, A., Kramann, R., Saritas, T., Marx, N., Dreher, M., Marx, G., & Simon, T. P. (2025). Implementation and One-Year Evaluation of Proenkephalin A in Critical Care. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26062602

Vancouver

Martin L, Martin C, Peine A, Imöhl M, Kersten A, Kramann R, et al. Implementation and One-Year Evaluation of Proenkephalin A in Critical Care. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26062602

BibTeX
@article{Martin2025,
  author = {Martin, Lukas and Martin, Caren and Peine, Arne and Imöhl, Matthias and Kersten, Alexander and Kramann, Rafael and Saritas, Turgay and Marx, Nikolaus and Dreher, Michael and Marx, Gernot and Simon, Tim-Philipp},
  title = {Implementation and One-Year Evaluation of Proenkephalin A in Critical Care},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26062602}
}
Kostenlos starten →